EUVIMEDEUVIMED entdecken
Crossref

A Biomimetic Nanoparticle Exerting Protection against Acute Liver Failure by Suppressing CYP2E1 Activity and Scavenging Excessive ROS

Qing Yao, Yingying Tang, Sheng Dai, Lihui Huang, Zewei Jiang, Shiming Zheng, Meng Sun, Yitianhe Xu, Ruijie Lu, Tuyue Sun, Huirong Huang, Xinyu Jiang und 4 weitere

Advanced Healthcare Materials · 2023

DOI: 10.1002/adhm.202300571 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2023. Verfasst von Qing Yao und 15 weiteren Autor:innen. Beteiligte Einrichtung: Wenzhou Municipal Key Laboratory of Pediatric Pharmacy, Department of Pharmacy, The Second Affiliated Hospital and Yuying Children's Hospital of Wenz…. Hauptthemen laut MEDLINE: Acetaminophen, Liver Failure, Acute. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Natural Science Foundation of Zhejiang Province, Wenzhou Municipal Science and Technology Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute liver failure (ALF) is a severe liver disease caused by many reasons. One of them is the overdosed acetaminophen (APAP), which is metabolized into N ‐acetyl‐p‐benzoquinone imine (NAPQI), an excessive toxic metabolite, by CYP2E1, resulting in excessive reactive oxygen species (ROS), exhausted glutathione (GSH), and thereafter hepatocyte necrosis. N ‐acetylcysteine is the Food and Drug Administration‐approved drug for detoxification of APAP, but it has limited clinical application due to the short therapeutic time window and concentration‐related adverse effects. In this study, a carrier‐free and bilirubin dotted nanoparticle (B/BG@N) is developed, which is formed using bilirubin and 18 β ‐Glycyrrhetinic acid, and bovine serum albumin (BSA) is then adsorbed to mimic the in vivo behavior of the conjugated bilirubin for hitchhiking. The results demonstrate that B/BG@N can effectively reduce the production of NAPQI as well as exhibit antioxidant effects against intracellular oxidative stress via regulating the nuclear factor erythroid 2‐related factor 2/heme oxygenase‐1 signal axis and reducing the production of inflammatory factors. In vivo study shows that B/BG@N can effectively improve the clinical symptom of the mice model. This study suggests that B/BG@N own increases circulation half‐life, improves accumulation in the liver, and dual detoxification, providing a promising strategy for clinical ALF treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetaminophenLiver Failure, AcuteAnimalsMiceCytochrome P-450 CYP2E1Reactive Oxygen SpeciesBiomimeticsLiverGlutathioneBilirubinIminesBenzoquinones

Stichwörter der Autor:innen

18β-glycyrrhetinic acidacute liver failurebilirubindual detoxificationnanoparticles

Substanzen

AcetaminophenCytochrome P-450 CYP2E1Reactive Oxygen SpeciesGlutathioneBilirubinN-acetyl-4-benzoquinoneimineIminesBenzoquinones

Autor:innen und Institutionen

  • Wenzhou Municipal Key Laboratory of Pediatric Pharmacy, Department of Pharmacy, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325027, P. R. China.
  • School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, 325035, P. R. China.
  • Key Laboratory of Structural Malformations in Children of Zhejiang Province, Wenzhou, 325027, P. R. China.
  • Faculty of Pharmacy, Zhejiang Pharmaceutical University, Ningbo, 315100, P. R. China.
  • Zhejiang Engineering Research Center for Innovation and Application of Intelligent Radiotherapy Technology, Wenzhou, 325000, P. R. China.
  • Wenzhou Key Laboratory of Basic Science and Translational Research of Radiation Oncology, Wenzhou, 325027, P. R. China.

ORCID-Profile: Longfa Kou

Förderung

  • Natural Science Foundation of Zhejiang Province
  • Wenzhou Municipal Science and Technology Bureau

Zitieren

APA

Yao, Q., Tang, Y., Dai, S., Huang, L., Jiang, Z., Zheng, S., Sun, M., Xu, Y., Lu, R., Sun, T., Huang, H., Jiang, X., Yao, X., Lin, G., Kou, L., & Chen, R. (2023). A Biomimetic Nanoparticle Exerting Protection against Acute Liver Failure by Suppressing CYP2E1 Activity and Scavenging Excessive ROS. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202300571

Vancouver

Yao Q, Tang Y, Dai S, Huang L, Jiang Z, Zheng S, et al. A Biomimetic Nanoparticle Exerting Protection against Acute Liver Failure by Suppressing CYP2E1 Activity and Scavenging Excessive ROS. Advanced Healthcare Materials. 2023. doi:10.1002/adhm.202300571

BibTeX
@article{Yao2023,
  author = {Yao, Qing and Tang, Yingying and Dai, Sheng and Huang, Lihui and Jiang, Zewei and Zheng, Shiming and Sun, Meng and Xu, Yitianhe and Lu, Ruijie and Sun, Tuyue and Huang, Huirong and Jiang, Xinyu and Yao, Xiaomin and Lin, Guangyong and Kou, Longfa and Chen, Ruijie},
  title = {A Biomimetic Nanoparticle Exerting Protection against Acute Liver Failure by Suppressing CYP2E1 Activity and Scavenging Excessive ROS},
  journal = {Advanced Healthcare Materials},
  year = {2023},
  doi = {10.1002/adhm.202300571}
}
Kostenlos starten →